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Intracellular signal transduction is often regulated by transient protein phosphorylation in
response to external stimuli. Insulin signaling is dependent on specific protein phosphoryla-
tion events, and analysis of insulin receptor substrate-1 (IRS-1) phosphorylation reveals a
complex interplay between tyrosine, serine, and threonine phosphorylation. The phospho-
specific antibody-based quantification approach for analyzing changes in site-specific phos-
phorylation of IRS-1 is difficult due to the dearth of phospho-antibodies compared with the
large number of known IRS-1 phosphorylation sites. We previously published a method
detailing a peak area-based mass spectrometry approach, using precursor ions for peptides, to
quantify the relative abundance of site-specific phosphorylation in the absence or presence of
insulin. We now present an improvement wherein site-specific phosphorylation is quantified
by determining the peak area of fragment ions respective to the phospho-site of interest. This
provides the advantage of being able to quantify co-eluting isobaric phosphopeptides
(differentially phosphorylated versions of the same peptide), allowing for a more comprehen-
sive analysis of protein phosphorylation. Quantifying human IRS-1 phosphorylation sites at
Ser303, Ser323, Ser330, Ser348, Ser527, and Ser531 shows that this method is linear (n  3; r2 
0.85  0.05, 0.96  0.01, 0.96  0.02, 0.86  0.07, 0.90  0.03, 0.91  0.04, respectively) over an
approximate 10-fold range of concentrations and reproducible (n  4; coefficient of variation 
0.12, 0.14, 0.29, 0.30, 0.12, 0.06, respectively). This application of label-free, fragment
ion-based quantification to assess relative phosphorylation changes of specific proteins will
prove useful for understanding how various cell stimuli regulate protein function by
phosphorylation. (J Am Soc Mass Spectrom 2010, 21, 1490–1499) © 2010 Published by
Elsevier Inc. on behalf of American Society for Mass SpectrometryUnderstanding changes in protein phosphoryla-tion in response to extracellular stimuli is vitalfor mapping intracellular signal transduction
pathways. Conventional methods for the identification of
protein phosphorylation sites, such as two-dimensional
phosphopeptide mapping, are technically difficult and
time-consuming. As a result, mass spectrometry tech-
niques have been developed as effective, reliable, and
faster applications for the identification and quantifica-
tion of protein phosphorylation [1, 2]. In particular,
Steen et al. [3] developed a label-free phosphorylation
quantification method in which normalization of phos-
phopeptides was made relative to numerous tryptic
peptides from the target protein. We modified this
approach to utilize the peak-area of the reconstructed
ion chromatogram for a phosphopeptide of interest and
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doi:10.1016/j.jasms.2010.05.009normalized this peak-area value against the average of the
peak areas for selected representative non-phosphorylated
peptides of the same protein that serve as endoge-
nous internal standards [4, 5]. Peak areas for each
peptide and phosphopeptide were obtained by inte-
gration of the appropriate reconstructed ion chromato-
grams for precursor ion masses. The trace generated in
a reconstructed ion chromatogram displays the inten-
sity (abundance) of a specified ion relative to HPLC
retention time in a format that is analogous to an
ultraviolet (UV) absorbance trace for an HPLC/UV run
[4, 5]. Relative quantification of each phosphopeptide
can then be obtained by comparing the normalized
peak-area ratios for untreated and treated samples.
Using this technique, we studied phosphorylation pat-
terns of IRS-1, an adaptor protein that lies distal to the
insulin receptor (IR) and acts as a key signaling protein
within the insulin signaling pathway [4–6]. Insulin
stimulates IR-mediated tyrosine phosphorylation of
IRS-1 at multiple sites, which then acts to recruit and
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relaying the insulin signal downstream [7]. While ty-
rosine phosphorylation of IRS-1 mimics the action of an
“on/off switch,” serine/threonine phosphorylation of
IRS-1 is a more complicated phenomenon, as at least 40
serine/threonine phosphorylation sites have been iden-
tified, and many of these sites modulate IRS-1 function
through a multitude of mechanisms [8]. In addition, not
all sites undergo insulin-stimulated phosphorylation,
as some serine/threonine sites undergo an insulin
stimulated decrease in phosphorylation, whereas other
serine/threonine sites are nonresponsive to insulin.
Furthermore, several IRS-1 serine phosphorylation sites
have been shown to be hyper-phosphorylated in insulin
resistant models, and this elevated serine phosphoryla-
tion of IRS-1 is thought to be involved in the pathogen-
esis of insulin resistance [9]. Therefore, characterizing
the insulin-regulated phosphorylation of IRS-1 is vital
for understanding insulin signaling. Through the use of
the peak area-based quantification approach, we as-
sessed the effect of insulin or TNF treatment of L6 cells
on the relative phosphorylation at two sites in human
IRS-1 [4]. Furthermore, we used this technique to iden-
tify/quantify site-specific phosphorylation of IRS-1 in
human vastus lateralis muscle obtained by needle bi-
opsy basally, and after insulin infusion in four healthy
volunteers, 22 serine/threonine phosphorylation sites
were identified; 15 were quantified [5].
Our previous studies using the precursor ion, peak
area-based mass spectrometry approach were success-
ful for the quantification of 15 insulin-regulated IRS-1
serine/threonine phosphorylation sites in vivo in hu-
man muscle [5]. Unfortunately, quantification data are
still lacking for a number of IRS-1 phosphorylation
sites, in part because quantification for peptides con-
taining more than one phosphorylation site can be
problematic. For example, the human IRS-1 tryptic
peptide corresponding to amino acids 303-325, in the
monophosphorylated state, is phosphorylated at four
different sites: Ser303, Ser307, Ser312, and Ser323. As a
result, the majority of the monophosphorylated pep-
tides, with the exception of the Ser312 phosphopeptide,
are not sufficiently separated by HPLC to permit indi-
vidual quantification. Another less complicated exam-
ple would be the human IRS-1 tryptic peptide corre-
sponding to amino acids 525-535, which can be detected
as a peptide phosphorylated at either Ser527 or Ser531,
and since both peptides consistently co-elute, quantifi-
cation data for these IRS-1 phosphorylation sites cannot
be obtained using the previously described approach.
Wolschin et al. demonstrated the relative quantifica-
tion of a mono-phosphorylated peptide by integrating
MS2- and MS3-extracted ion traces and observed an
improved S/N ratio resulting from the MS3 ion trace as
compared to the MS2 ion trace [10]. Because they only
observed the loss of phosphoric acid from the peptide,
their approach is not suitable for discerning co-eluting
isobaric phosphopeptides. More recently, we developed
an MS2 fragment ion-based phosphorylation quantifica-tion method for the ATP synthase  subunit [11]. One
main reason for using MS2 fragment ions instead of
precursor ions for the ATP synthase  subunit is that
the MS2 ions acquired using the LTQ analyzer offered
more sensitivity than the precursor ions acquired by the
FTICR analyzer. Three mono-phosphorylated peptides
of the ATP synthase  subunit that were resolved by
HPLC were quantified using respective high intensity
fragment ions with m/z values greater than that of the
precursor ion. However, to the best of our knowledge,
application of the label-free, unique fragment ion-based
quantification approach to assess co-eluting isobaric
phosphopeptide isoforms in a complex biological sam-
ple has not been reported.
In the present work, we utilized the peak area of
site-specific fragment ions as an alternative to the
parent ion, which allows for co-eluting isobaric phos-
phorylated peptides to be quantified using b and y ions
unique to each phosphorylation isoform acquired using
the LTQ mass analyzer. Using this approach, we show
that MS2/MS3 fragment ions corresponding to phos-
phorylated tryptic peptides of IRS-1 can be detected in
a linear and reproducible manner. We then used this
new method to assess the effect of insulin treatment of
Chinese hamster ovary cells overexpressing the IR
(CHO/IR) on the relative phosphorylation at six sites in
overexpressed human IRS-1.
Methods
Materials
The following suppliers were used: sequencing-grade
trypsin, Sigma (St. Louis, MO); C18 ZipTip, Millipore
(Billerica, MA, USA); anti HA.11 antibody, Covance
(Berkeley, CA, USA). Chinese hamster ovary cells over-
expressing the insulin receptor (CHO/IR) were a gift
from Dr. Feng Liu (University of Texas Health Science
Center at San Antonio, TX, USA). The cDNA encoding
full-length wild-type human IRS-1 was a gift from Dr.
C. Ronald Kahn (Harvard University, MA, USA). Bo-
vine Serum Albumin (BSA) digest was obtained from
Michrom BioResources (Alburn, CA, USA).
Adenoviruses
Adenoviruses encoding green fluorescence protein
(GFP, as an adenovirus control) and hIRS-1 were
produced by using the AdEasy system (Quantum
Biotechnologies, Montreal, Canada). The cDNA en-
coding HA-tagged hIRS-1 (pBEX-hIRS-1 was pre-
pared as previously described [12] was cloned into
the pAdTrack-CMV transfer vector using EcoRV and
Xba I restriction sites. The hIRS-1-HA encoding se-
quence was then transferred into the pAdEasy viral
DNA plasmid by homologous recombination in the
BJ5183 Escherichia coli strain. The recombinant adenovi-
ral construct was transfected in HEK293 cells to pro-
duce viral particles. Adenoviruses were purified by
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was estimated for GFP expression using an Olympus
(Center Valley, PA, USA) CK40 fluorescence micro-
scope [12].
Cell Culture, Transfection, Immunoprecipitation,
and Western Blot Analysis
CHO/IR cells were grown in HAM’S F-12 medium
(Invitrogen, Carlsbad, CA, USA), supplemented with
10% fetal bovine serum and 1%penicillin/streptomycin. For
adenovirus experiments, cells were transduced with
hIRS-1 adenovirus (Ad-hIRS-1). Twenty-four hours
post-transduction, cells were serum-starved for 5 h,
treated with or without 100 nM insulin 15 min and
lysed on ice in 300 L of lysis buffer (50 mMHEPES, pH
7.6, 150 mMNaCl, 1% Triton X-100, 10 mMNaF, 20 mM
sodium pyrophosphate, 20 mM -glycerol phosphate, 1
mM sodium orthovanadate, 10 g/mL leupeptin, 10
g/mL aprotinin, and 1 mM phenylmethylsulfonyl
fluoride). Cell lysates were centrifuged (10,000  g,
4 °C, 10 min), and the clarified supernatants were used
for immunoprecipitation. For immunoprecipitation, cell
lysates were incubated with specific antibodies conju-
gated to protein G-agarose beads overnight at 4 °C with
gentle rotation. Immunoprecipitates were washed ex-
tensively with ice-cold PBS and the proteins bound to
beads were eluted by heating at 95 °C for 4 min in SDS
sample loading buffer. Eluted proteins were separated by
10% SDS-PAGE and were stained with Coomassie blue.
In-Gel Digestion
The gel portions containing IRS-1 were excised, placed
in a 0.6-mL polypropylene tube, destained twice with
300 L of 50% acetonitrile (ACN) in 40 mM NH4HCO3
and dehydrated with 100% ACN for 15 min. After
removal of ACN by aspiration, the gel pieces were
dried in a vacuum centrifuge at 60 °C for 30 min.
Trypsin (250 ng; Sigma Chemical Co., St. Louis, MO,
USA) in 20 L of 40 mM NH4HCO3 was added and the
samples were maintained at 4 °C for 15 min before the
addition of 50 L of 40 mM NH4HCO3 containing three
10 fmol/L peptides to serve as internal standards
(Bradykinin Fragment 2-9, B1901, -Sheet Breaker Pep-
tide, S7563, and Anaphylatoxin C3a fragment, A8651;
Sigma Chemical Co., St. Louis, MO, USA).
The digestion was allowed to proceed at 37 °C over-
night and was terminated by addition of 10 L 5%
formic acid (FA). After further incubation at 37 °C for 30
min and centrifugation for 1 min, each supernatant was
transferred to a clean polypropylene tube. The extrac-
tion procedure was repeated using 40 L of 0.5% FA,
and the two extracts were combined. The resulting
peptide mixtures were purified by solid-phase extrac-
tion (C18 ZipTip; Millipore) after sample loading in
0.05% heptafluorobutyric acid:5% FA (vol/vol) and
elution with 4 L 50% ACN:1% FA (vol/vol) and 4 L80% ACN:1% FA (vol/vol), respectively. The eluates
were combined and dried by vacuum centrifugation
and 10 L of 0.025%HFBA/0.1% FA:2% ACN (vol/vol)
were added.
Mass Spectrometry
HPLC-ESI-MS/MSn was performed on a Thermo
Finnigan (San Jose, CA, USA) LTQ-FTICR fitted with
a PicoView nanospray source (New Objective,
Woburn, MA, USA). On-line HPLC was performed
using a Michrom BioResources Paradigm MS4 micro
two-dimensional HPLC (Alburn, CA, USA) with a
PicoFrit column (New Objective, 75 m i.d., packed
with ProteoPep II C18 material, 300 Å); mobile phase,
linear gradient of 2% to 27% ACN in 0.1% FA in 65 min,
a hold of 5 min at 27% ACN, followed by a step to 50%
ACN, hold 5 min, and then a step to 80%; flow rate, 400
nL/min.
A “top-10” data-dependent MS/MS analysis was
performed (acquisition of a full scan spectrum followed
by collision-induced dissociation (CID) mass spectra of
the 10 most abundant ions in the survey scan) to
identify IRS-1 peptides and to obtain their HPLC reten-
tion times, as described before [4]. For quantification,
the following multi-segment strategy was employed:
one survey scan, followed by one parent-list CID scan
and six targeted CID scans. Included in the parent list
were the 2 or 3 charge states of seven representative
IRS-1 peptides selected from the prominent ions rep-
roducibly observed in the top-10 data-dependent
tandem-MS analysis. These peptides were used as inter-
nal standards for IRS-1 protein content (see below).
They were selected according to the following criteria:
(1) detected by HPLC-ESI-MS with high intensity
among IRS-1 peptides; (2) no missed cleavage observed;
(3) no methionine in the sequence to avoid variability
due to methionine oxidization and no N-terminal Gln
residues. The 2 or 3 ions of the phosphopeptides of
interest were placed on the target list. To assess the
relative quantities of a large number of phosphopep-
tides in each experiment and yet still maintain accept-
able mass analysis cycle times, the targeted m/z values
were grouped into segments based on their expected
HPLC retention times with a minimum 10-min reten-
tion time window for each peptide.
Tandem mass spectra were extracted from Xcalibur
‘RAW’ files and charge states were assigned using the
Extract_MSN script that is a component of Xcalibur 2.0
SR2 (Thermo Fisher; San Jose, CA, USA). The fragment
mass spectra were then searched against the human
SwissProt_v52.2 database (16,135 entries) using Mascot
(Matrix Science, London, UK; version 2.1). The search
variables that were used were: 5 ppmmass tolerance for
precursor ion masses and 0.5 Da for product ion masses;
digestion with trypsin; a maximum of two missed
tryptic cleavages; variable modifications of oxidation of
methionine and phosphorylation of serine, threonine,
and tyrosine. Cross-correlation of Mascot search results
1493J Am Soc Mass Spectrom 2010, 21, 1490–1499 QUANTIFICATION OF ISOBARIC PHOSPHOPEPTIDESwith X! Tandem was accomplished with Scaffold (ver-
sion Scaffold-01_06_19; Proteome Software, Portland,
OR, USA). Probability assessment of peptide assign-
ments and protein identifications were made through
the use of Scaffold. Only peptides with 95% probabil-
ity were considered. Assignments of the phosphopep-
tides were confirmed by manual comparison of the
tandem mass spectra with the predicted fragmentation
generated in silico by the MS-Product component of
Protein Prospector (http://prospector.ucsf.edu).
Peak areas for each peptide were obtained by inte-
gration of the appropriate reconstructed ion chromato-
grams with 5 ppm error tolerance for precursor ion
masses acquired using the FTICR and 0.5D for the
fragment ions acquired using the LTQ mass analyzer.
The reconstructed ion chromatograms allow one to
express the intensity (abundance) of ions relative to
HPLC retention times in chromatogram form, analo-
gous to analysis of UV absorbance during an HPLC run.
The peak areas (using MS2/MS3 fragment ions) for the
phosphopeptides were then normalized against the
average peak area (using precursor ions) for the seven
representative IRS-1 peptides (endogenous standards).
Relative quantification of each phosphopeptide was
obtained by comparing normalized peak-area ratios for
control and insulin treated samples.
Results and Discussion
Analysis of Phosphopeptides Derived from Human
IRS-1
IRS-1 was isolated from CHO/IR cells and mass spec-
trometry analysis was performed as described in Meth-
ods. Table 1 lists the IRS-1 phosphopeptides detectable
by MS and their respective predominant phosphoryla-
tion sites. In addition to these phosphopeptides, we
chose seven non-phosphorylated peptides of IRS-1 that
were detected in all MS analyses, and these peptides
served as endogenous internal standards as a measure
of the abundance of total IRS-1 present per sample
(Table 2). Analysis of IRS-1 expressed in CHO/IR cells
revealed that although some phospho-IRS-1 peptides
Table 1. IRS-1 phosphopeptides
Start Stop Peptide seq
303 325 pSRTEpSITATpSPASMV
328 353 ASpSDGEGTMSRPASVD
444 457 SVpTPDSLGHpTPPAR
494 520 CpTPGTGLGTSPALAGD
525 538 THpSAGTpSPTITHQK
627 638 KGpSGDYMPMpSPK
892 922 pSPGEYVNIEFGSDQSGY
999 1016 QSYVDTpSPAAPVSYAD
1075 1081 VNLpSPNR
1098 1112 RHpSSETFSSTPSATR
1099 1112 HSpSETFSSTPSATR
1141 1161 HpSpSApSFENVWLRPG
1221 1236 RpSpSEDLSAYASISFQKexist predominantly as a single, monophosphorylated
peptide (aa494-520, pThr495), several IRS-1 tryptic pep-
tides, such as aa303-325, aa328-353, aa525-535, and
aa627-638, for example, contain multiple phosphoryla-
tion sites (Figure 1). This presents a problem, as the
different monophosphorylated versions of the same
peptide possess the same mass/charge value, rendering
them indistinguishable from each other during peak
area analysis of precursor ions if they co-elute. As a
result, we chose to target the mass/charge value of the
parent ions of the particular phosphopeptides, and use
the resulting peak areas of the fragment b and y ions
specific to the sites of interest for quantification of
phosphorylation. A list of the fragment b and y ions that
were found to be suitable for analysis for each phospho-
site within each phospho-peptide of interest is shown in
Table 3. It is noted that for some phosphopeptides,
fragment ions from MS2 spectra gave high-quality
quantification results, while for other phosphopeptides,
fragment ions from MS3 were superior.
Linearity and Reproducibility of MS3 Product Ions
from Synthetic Phosphopeptides Corresponding to
the Tryptic Phosphopeptides of IRS-1
Phosphorylated at Either Ser527 or Ser531
To confirm the validity of the MS2/MS3-based phospho-
quantification approach, linearity and reproducib-
ility experiments were performed using synthetic
phosphopeptides corresponding to the tryptic phosphopep-
tides of IRS-1 phosphorylated at either Ser527 or Ser531.
We performed linearity experiments using these syn-
thetic phosphopeptides mixed with a tryptic digest of
bovine serum albumin (BSA), where the amount of
phosphopeptides was varied from 50 to 400 fmol while
the amount of BSA digest was held constant at 200 fmol.
We found that doubling the amount of either the
pSer527 or pSer531 peptides resulted in an increase in
the ratio of the phosphorylated peptide to the internal
standards (BSA digests) by a factor of 1.92  0.22 and
1.87  0.09, respectively (Supplemental Table 1, which
ce Phosphorylation site
PGpSFR Ser303, Ser307, Ser312, Ser323
VpSPSTNR Ser330, Ser348
Thr446, Thr453
AADLDNR Thr495
Ser527, Ser531
Ser629, Ser636
PVAFHSSPSVR Ser892
Ser1005
Ser1078
Ser1100
Ser1101
APK Ser1142, Ser1143, Ser1145uen
GGK
GSP
EAAS
LSG
MR
ELGG
Ser1222, Ser1223
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These results suggest that the changes in phosphoryla-
tion observed using this method are representative of
relative fold changes in the amount of phosphorylation
a protein undergoes at specific sites under various
cellular stimuli. The quantification by peak area of
product of b and y ions from both the pSer527 and
pSer531 phosphopeptides displayed a linear relation-
ship over the ten-fold concentration range (Figure 2).
We also tested the reproducibility of peak area assign-
ment values for the MS3 fragment b and y ions. Equal
amounts (400 fmol) of the pSer527 and pSer531 syn-
thetic phosphopeptides were combined with 200 fmol
of BSA digest and the mixtures were analyzed by
HPLC-ESI-MS/MS as described in the Methods section.
The peak area values obtained for the pSer527 or the
pSer531 phosphopeptide were normalized to the aver-
age peak areas for the BSA digest peptides for each of
the four experiments, and a coefficient of variation was
calculated for each phosphorylation site. The coeffi-
cients of variation for the normalized peak area values
of the MS3 product ions for the synthetic phosphopep-
tides corresponding to pSer527 and pSer531 were 14%
and 11%, respectively, suggesting that the use of the
Table 2. IRS-1 internal standard peptides
Start Stop Peptide sequence
82 89 HLVALYTR
178 184 NLIGIYR
287 301 HHLNNPPPSQVGLTR
639 651 SVSAPQQIINPIR
876 891 EQQQQQQPLLHPPEPK
1017 1028 TGIAAEEVSLPR
1113 1140 VGNTVPFGAGAAVGGGGGSSSSSEDVKRFigure 1. IRS-1 phosphopeptides containinpeak area values of product b and y ions provides a
reproducible approach to quantify phosphorylation of
different sites within the same peptide (Supplemental
Table 2).
Reproducibility of MS2/MS3 Product Ions for the
Quantification of Phosphorylation
To confirm the validity of the MS2/MS3-based phospho-
quantification approach in a complex biological sys-
tem, we tested the reproducibility of peak area assign-
ment values for the MS2/MS3 fragment b and y ions.
IRS-1 was isolated from CHO/IR cells as described in
Methods and equal amounts of the same sample were
separated by SDS-PAGE in four separate lanes. The
bands corresponding to IRS-1 were excised and pre-
pared as described in the Methods section, and each
IRS-1 tryptic digest was analyzed by HPLC-ESI-MS/MS
as described in Methods. Table 4 summarizes the re-
sults for the four independent experiments. For the
seven non-phosphorylated IRS-1 standard peptides, an
average of the peak area values for the precursor ions
acquired in the FTICR was taken and the coefficient of
Theoretical
1H peptide
mass (AMU)
Quantified
m/z value
Quantified
peptide
charge state
Elution
time (min)
972.56 486.79 2 33.3
848.50 424.75 2 40.7
1666.88 556.30 3 31.4
1422.80 711.91 2 48.5
1924.99 642.33 3 36.9
1242.67 621.84 2 46.6
2507.21 836.41 3 43.2g multiple monophosphorylation sites.
id (98
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area values obtained for the seven IRS-1 peptides for
each experiment were then used for normalization of
phosphopeptide peak areas for each of the 4 experi-
ments, and a coefficient of variation was calculated for
each phosphorylation site (Table 4). The coefficients of
variation for the normalized peak area values of the
MS2/MS3 product ions for pSer303, pSer323, pSer330,
pSer348, pSer527, pSer531 were: 12%, 14%, 29%, 30%,
12%, and 6%, respectively. In comparison, the two
phosphorylation sites (pSer629 and pSer636) for
which we used the loss of phosphoric acid (98D) and
SOCH4 (64D) from the parent ion for phosphorylation
quantification, compared with the product b and y
ions, had coefficients of variation of 6 and 9%,
y = 46.4x - 834.92
R² = 0.9511
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Figure 2. Linearity of MS3-based quantification of phosphoryla-
Table 3. IRS-1 fragment ions for quantification
Start Stop Peptide sequence
Pho
303 325 pSRTESITATSPASMVGGKPGpSFR
328 353 ASpSDGEGTMSRPASVDGSPVpSPSTNR
525 538 THpSAGTpSPTITHQK
627 638 KGpSGDYMPMpSPK
*The highest fragment ion in the MS3 spectrum, loss of phosphoric ac
and pSer636 were resolved by HPLC.tion for synthetic phosphopeptides.respectively. In all analyses, the tandem mass spectra
obtained for each peptide of interest were used to
verify identity of the phosphorylation site. The rela-
tively low coefficients of variance for the results in
Table 4 demonstrate that the use of peak area values
of product b and y ions provides a reproducible
approach to quantify phosphorylation of different
sites within the same phosphopeptide.
Linearity of MS2/MS3 Product Ions for the
Quantification of Phosphorylation
To determine linearity of this approach, three separate
tryptic digests of IRS-1 were independently analyzed by
HPLC-ESI-MS/MS over an approximate 10-fold con-
centration range (achieved by serial dilution of each
tryptic digest). There was a linear relationship for the
average peak areas of the seven IRS-1 peptide standards
in the three experiments performed, and the regression
equations were y  1e06 x  8.6e04, y  1e06 x 
4.5e05, and y  6e05 x  9.5e04, with r2  0.99, 0.88,
and 0.99, respectively. Table 5 shows the r2 values for
the three experiments performed, and Figure 3 shows
representative linearity graphs for both the standard
peptides and all phosphorylation sites quantified by
peak area of product b and y ions. Each phosphoryla-
tion site quantified by peak area of product of b and y
ions displayed a linear relationship over the ten-fold
concentration range.
MS2/MS3-Based Quantification of Insulin
Stimulated IRS-1 Phosphorylation
Since the peak area of the MS2/MS3 product ions
exhibited both linearity and reproducibility, we used
this method to quantify the effects of insulin on IRS-1
phosphorylation in CHO/IR cells. Adenoviruses encod-
ing human IRS-1 were used to infect CHO/IR cells, and
rylation
e
MS2 or
MS3?
Product ion
(charge state) Mass
Elution
time (min)
03 MS3 y21 (2) 1049.02 43
23 MS3 b14 (1) 1436.67 42.7
MS3 y9 (1) 886.49 42.7
30 MS2 y20 (2) 1009.98 35.6
MS2 y22 (2) 1103.01 35.6
MS2 y11 (1) 1116.53 35.6
48 MS2 y8 (1) 937.41 34.8
MS2 y20 (2) 1049.96 34.8
MS2 b11 (1) 1095.44 34.8
27 MS3 y11 (1) 1140.60 24.5
31 MS3 y11 (1) 1122.59 24.4
29 MS3 [M2H-98-64]2 624.29* 25.1
36 MS3 [M2H-98-64]2 624.29* 23.1
D) and SOCH4 (64D) from the parent ion. Peptides containing pSer629spho
sit
Ser3
Ser3
Ser3
Ser3
Ser5
Ser5
Ser6
Ser624 h later the cells were serum-starved for 5 h and
8E-0
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immunoprecipitated and phosphorylation was ana-
lyzed by HPLC-ESI-MS/MS as described in the Meth-
ods section. Insulin-stimulated changes in relative
phosphorylation of IRS-1 from three independent ex-
periments were expressed as the fold change over basal
(Figure 4). The normalized peak areas for the MS3
fragment ions containing either pSer303, pSer323, or
pSer330 of IRS-1 were only slightly affected by insulin:
1.07  0.13, 0.91  0.03, 0.94  0.26, respectively. In
contrast, there was a 50% decrease in the normalized
peak area for pSer348 specific MS2-fragment ions iso-
lated from insulin treated cells compared to untreated
cells (0.47  0.14), whereas Ser629 underwent a 20%
decrease upon insulin stimulation (0.80  0.09). On the
other hand, insulin increased the phosphorylation of
Ser527, Ser531, and Ser636: 1.56  0.08, 1.27  0.09, and
1.32  0.07 fold, respectively.
Conclusions
In our previous reports quantifying the effects of insulin
on IRS-1 phosphorylation, our efforts were limited to
studying phosphorylated peptides that did not co-elute.
This presents a problem for a protein like IRS-1, which
has at least 40 phosphorylation sites, with a number of
these sites residing in the same tryptic peptide. In the
case of IRS-1, the tryptic phosphopeptides that possess
multiple phosphorylation sites are not usually detected
as multi-phosphorylated peptides but, rather, appear as
a collection of differentially monophosphorylated pep-
tides, all of which possess identical m/z values. This
property renders the phosphopeptides indistinguish-
able using the previous, precursor ion-based quantifi-
Table 4. Coefficients of variation for reproducibility experiment
Expt. 1 Expt. 2 E
STDs 4.64E07 5.91E07 5.7
S303 9.42E-05 9.25E-05 9.6
S323 1.09E-04 8.05E-05 8.8
S330 4.87E-03 3.03E-03 2.5
S348 2.02E-03 1.25E-03 1.1
S527 6.26E-04 5.79E-04 6.4
S531 1.19E-04 1.15E-04 1.0
S629 1.27E-03 1.39E-03 1.2
S636 1.13E-03 1.15E-03 1.2
Table 5. r2 Values for linearity experiments
Expt. 1 Expt. 2 Expt. 3 AVE SEM
STDs 0.99 0.88 0.99 0.95 0.04
S303 0.76 0.85 0.95 0.85 0.05
S323 0.98 0.93 0.97 0.96 0.01
S330 1.00 0.93 0.97 0.96 0.02
S348 0.95 0.71 0.92 0.86 0.07
S527 0.94 0.93 0.85 0.90 0.03
S531 0.82 0.96 0.95 0.91 0.04
S629 0.96 0.92 0.91 0.93 0.01
S636 0.68 0.97 0.88 0.84 0.09cation approach, unless sufficient HPLC separation is
achieved (as is the case for the pSer629 and pSer636
containing peptide). For example, Ser303 and Ser323 are
found in the aa303-325 tryptic peptide, and both have a
mass/charge value of m/z 807.38 (3). By analyzing the
peak area of the MS3 product ions created from target-
ing the m/z 807.38 parent ion, quantification data can be
obtained for each of the sites. Unfortunately, there are
limits to this approach, as fragment ions from a phos-
phorylation site that lies between 2 other phosphoryla-
tion sites within the same peptide cannot be distin-
guished by mass/charge values. MS4 or higher order of
MSn may be needed to quantify those sites. It is also
important to note that phosphopeptide fragmentation is
variable, and both MS2 and MS3-based targeting ap-
proaches must be tested for each site of interest, since
some fragment b and y ions are more easily detected by
MS2 versus MS3 and vice versa. A major advantage of
this approach is that it is relatively straight forward,
compared with alternative mass spectrometry-based
phosphorylation quantification strategies, which in-
clude the use of stable isotope labeled synthetic peptide
analog internal standards [13, 14], metabolic labeling
[15–18], derivatization [19–21], and evaluation of MS
peak intensities of peptide(s) derived from proteins
added before digestion [22] or from the protein of
interest [3, 23]. One major difference between the MS2-
based approach we described previously for ATP syn-
thase  phosphorylation and the present approach is
that unique, monophosphorylated peptides were quan-
tified for ATP synthase , while in the present ap-
proach, the unique ions for a specific phosphopeptide
isoform were selected due to the issue of co-eluting
isobaric phosphopeptides.
In conclusion, we report here an improvement to our
previously established, MS-based relative quantifica-
tion of protein phosphorylation method. This new
method utilizes the normalized peak area of MS2/MS3
derived fragment ions specific to individual phos-
phopeptide isoforms. This improvement provides the
additional advantage of quantifying changes in the
relative phosphorylation of co-eluting isobaric phos-
phopeptides, allowing for a more comprehensive un-
derstanding of protein phosphorylation. Obviously, it
can be also used to quantify phosphopeptides that were
3 Expt. 4 AVE C.V.
07 5.92E07 5.55E07 0.11
5 1.18E-04 1.00E-04 0.12
5 1.06E-04 9.60E-05 0.14
3 4.40E-03 3.72E-03 0.29
3 2.03E-03 1.61E-03 0.30
4 4.84E-04 5.83E-04 0.12
4 1.08E-04 1.12E-04 0.06
3 1.34E-03 1.30E-03 0.06
3 1.36E-03 1.23E-03 0.09s
xpt.
2E
3E-0
9E-0
8E-0
4E-0
2E-0
5E-0
2E-0resolved by HPLC, as MS2/MS3 derived fragment ions
d qu
1497J Am Soc Mass Spectrom 2010, 21, 1490–1499 QUANTIFICATION OF ISOBARIC PHOSPHOPEPTIDESmay offer higher sensitivity as compared to using
precursor ions. We present data supporting both the
Figure 3. Linearity of MS2/MS3-basereproducibility and linearity of this approach, and inaddition, we present phospho-quantification data for
IRS-1 in a typical signaling experiment under basal and
antification of IRS-1 phosphorylation.insulin stimulated conditions. The fact that this ap-
1498 LANGLAIS ET AL. J Am Soc Mass Spectrom 2010, 21, 1490–1499proach can be used to quantify multiple phosphoryla-
tion sites simultaneously without the use of phosphor-
ylation site-specific antibodies makes this an ideal
technique for understanding complex patterns of pro-
Figure 4. Quantification of insutein phosphorylation.Acknowledgments
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